Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 6, 2002 CD
Six back issues from 2002 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 6 No. 1 January/February 2002 Compounding for Pain Management and Dental Medicine
Vol. 6 No. 2 March/April 2002 Dermatologic Compounding
Vol. 6 No. 3 May/June 2002 Health, Wellness, Geriatrics
Vol. 6 No. 4 July/August 2002 Compounding for BHRT and Legal and Regulatory Issues
Vol. 6 No. 5 September/October 2002 Veterinary Compounding
Vol. 6 No. 6 November/December 2002 Sterile Preparations and Pediatric Compounding

Volume 6, 2002 CD ARTICLES

Volume6, 2002 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Vol. 6 No. 1 4
Compounding with Controlled Substances Vol. 6 No. 1 8
The Problem of Drug Diversion Vol. 6 No. 1 11
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Vol. 6 No. 1 13
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh Vol. 6 No. 1 16
Benzocaine 2% Sorbitol Antigag Candy Vol. 6 No. 1 17
Tetracycline 5%, Dexamethasone 0.2% Periodontal Gel Vol. 6 No. 1 17
Fluoride 0.25-mg Sugar-Free Hard Candy Vol. 6 No. 1 17
Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity Vol. 6 No. 1 19
Creating a Productivity Measurement Tool for a Home Infusion Pharmacy Vol. 6 No. 1 24
Team Building For Success Vol. 6 No. 1 27
Technology Spotlight: Capsule-Filling Machines Vol. 6 No. 1 31
Compounding in History: Dental Considerations Vol. 6 No. 1 32
Toothpowder Vol. 6 No. 1 33
Liquid Dentifrice Vol. 6 No. 1 33
Toothache Wax Vol. 6 No. 1 33
Basics of Compounding Biotechnologic Preparations Vol. 6 No. 1 34
Analgesic NSAID Suppositories Vol. 6 No. 1 40
Capsaicin 0.075% Topical Spray Vol. 6 No. 1 41
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) Vol. 6 No. 1 42
Diltiazem HCl 2% Topical Gel Vol. 6 No. 1 43
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection Vol. 6 No. 1 44
Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO) Vol. 6 No. 1 45
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules Vol. 6 No. 1 46
Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream Vol. 6 No. 1 47
Morphine Sulfate 5-mg/0.1-mL Nasal Spray Vol. 6 No. 1 48
Oxycodone 25-mg Slow-Release Capsules Vol. 6 No. 1 49
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Vol. 6 No. 1 50
New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Vol. 6 No. 1 55
Poloxamers, Featured Excipient: Vol. 6 No. 1 58
Safety for Employees in the Compounding Work Area Vol. 6 No. 1 60
Physical and Chemical Stability of Morphine Sulfate 5-mg/mL and 50-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 62
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 66
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Vol. 6 No. 1 70
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Vol. 6 No. 1 74
Calculations Vol. 6 No. 1 77
PostScription: Regulatory Uncertainty Requires Professional Responsibility Vol. 6 No. 1 80
Compounding for Skin Care: An Interview with John Hollis, RPh Vol. 6 No. 2 85
Mary Kay Inc: Compounding in a Cosmetics Megacorporation Vol. 6 No. 2 88
Hair Styling Gel Formula-Example Formulation Vol. 6 No. 2 90
Skin Moisturizer Formula Vol. 6 No. 2 91
Cream Formulation (Oil-in-Water Emulsion) Vol. 6 No. 2 91
Options in Wound Care Vol. 6 No. 2 92
Dermatologic and Cosmetic Lines from Compounding Pharmacies in Brazil Vol. 6 No. 2 96
Excerpts from and Reviews of Current Published Literature: Treating Dermatologic Conditions Vol. 6 No. 2 98
Book Review: The Wrinkle Cure Vol. 6 No. 2 101
Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles Vol. 6 No. 2 102
Lotion Vol. 6 No. 2 103
Dusting Powder Vol. 6 No. 2 103
Hand Cream Vol. 6 No. 2 103
Stick Formulation Vol. 6 No. 2 104
Hard-Stick Formulation Vol. 6 No. 2 104
Soft-Stick Formulation (Clear Stick Base) Vol. 6 No. 2 104
Blemish-Hiding Stick Vol. 6 No. 2 104
Clear Shampoo Vol. 6 No. 2 104
Cream Shampoo Vol. 6 No. 2 104
Liquid Deoderant and/or Antiperspirant Vol. 6 No. 2 105
Shaving Cream (Brushless) Vol. 6 No. 2 105
Shaving Cream (Brushless) Vol. 6 No. 2 105
Astringent Mouthwash Vol. 6 No. 2 105
Deodorant Stick Vol. 6 No. 2 105
Developing a Successful Compounding Business in a Small Town Vol. 6 No. 2 108
A Guide to Effective Media Relations Vol. 6 No. 2 111
Technology Spotlight: Waring Blenders Vol. 6 No. 2 114
Wish You Were Here: The History of Pharmacy Museum at the Arizona College of Pharmacy, Tucson, Arizona Vol. 6 No. 2 116
Tablet Cutting Vol. 6 No. 2 118
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Vol. 6 No. 2 120
Medications Discontinued in the United States Vol. 6 No. 2 123
Antipruritic Gel Vol. 6 No. 2 126
Cold Sore Ointment Vol. 6 No. 2 127
Glycolic Acid 15% Gel Vol. 6 No. 2 128
Halobetasol and Calcipotriene Cream Vol. 6 No. 2 129
Medicated Aftershave Lotion Vol. 6 No. 2 130
Metronidazole 1% Topical Spray Vol. 6 No. 2 131
Mycophenolate Mofetil 2% Topical Cream Vol. 6 No. 2 132
Tranilast 0.8% for Iontophoresis Vol. 6 No. 2 133
Tranilast Topical 2% Penetrating Mixture Vol. 6 No. 2 134
Wart Remover Mixture Vol. 6 No. 2 135
Veterinary Compounding for Ferrets Vol. 6 No. 2 136
Sterilization of Talc for Use in Pleurodesis Vol. 6 No. 2 140
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Vol. 6 No. 2 142
Polysorbates, Featured Excipient: Vol. 6 No. 2 147
Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory Vol. 6 No. 2 149
Calculations Vol. 6 No. 2 151
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags Vol. 6 No. 2 152
Stability of 4-Aminopyridine and 3,4-Diaminopyridine Oral Capsules Vol. 6 No. 2 155
PostScription-Ensuring Compounding Excellence: Quality Control or Quality Assurance? Vol. 6 No. 2 160
Healthful Living: Good Practices for Good Health Vol. 6 No. 3 164
Compounding for Geriatrics Patients Vol. 6 No. 3 168
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease Vol. 6 No. 3 171
Lollipops: The Evolution of a Dosage Form Vol. 6 No. 3 178
Book Reviews: Wellness, Nutrition and Geriatrics Vol. 6 No. 3 180
Compounding in History: The Road to Wellville Vol. 6 No. 3 184
Mild Laxative Vol. 6 No. 3 185
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel Vol. 6 No. 3 185
How To Perform a Study in Your Pharmacy with Little or No Effort Vol. 6 No. 3 186
Technology Spotlight: Electric Mixing Machines Vol. 6 No. 3 188
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam Vol. 6 No. 3 189
Medications Discontinued in the United States Vol. 6 No. 3 193
Basics of Compounding: Iontophoresis, Part 1 Vol. 6 No. 3 194
Anhydrous Emollient Dry Skin Lotion Vol. 6 No. 3 199
Antiseptic Protective Ointment Vol. 6 No. 3 200
Camphor, Menthol, and Eucalyptol Rubefacient Ointment Vol. 6 No. 3 201
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Vol. 6 No. 3 202
Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO Vol. 6 No. 3 203
Misoprostol 0.0024%, Metronidazole 2%, and Pentoxifyline 5% Decubitus Ulcer Cream Vol. 6 No. 3 204
Nicotine 2-mg Lollipops Vol. 6 No. 3 205
Nicotine Medication Stick Vol. 6 No. 3 206
Podophyllum, Lactic Acid, and Salicylic Acid Wart Mixture Vol. 6 No. 3 207
Vitamin B12 1-mg/mL Nasal Spray Vol. 6 No. 3 208
The Treatment of Canine Atopic Disease Vol. 6 No. 3 210
pH and Osmolarity, A Review of Vol. 6 No. 3 216
Sorbitan Esters, Featured Excipient: Vol. 6 No. 3 221
Developing Standard Operating Procedures Vol. 6 No. 3 224
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags Vol. 6 No. 3 226
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 3 230
Stability of Cefotaxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 6 No. 3 234
Calculations Vol. 6 No. 3 237
PostScription: Building Relationships with Special Patient Populations Vol. 6 No. 3 240
A Review of Current Research on the Effects of Progesterone Vol. 6 No. 4 245
The Hormonal Link to Breast Cancer: The Estrogen Matrix Vol. 6 No. 4 250
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Vol. 6 No. 4 255
Establishing an Andropause Practice Vol. 6 No. 4 259
Compounding and the Courts Vol. 6 No. 4 263
Facilities and Procedures for Compounding Hazardous Drugs Vol. 6 No. 4 267
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Vol. 6 No. 4 271
Legal Issues: Technicians in the Compounding Pharmacy Practice Vol. 6 No. 4 274
Excerpts from and Reviews of Current Published Literature: Pharmacy Administration and Other Topics of Interest Vol. 6 No. 4 278
Magnetic Iron “Whiskers” in Cereals Vol. 6 No. 4 281
Wish You Were Here: Chicago, Illinois Vol. 6 No. 4 284
Medications Discontinued in the United States Vol. 6 No. 4 286
Basics of Compounding for Iontophoresis, Part II Vol. 6 No. 4 288
Lidocaine HCl 4% Solution for Iontophoresis Vol. 6 No. 4 290
Dexamethasone 4-mg/mL Solution for Iontophoresis Vol. 6 No. 4 290
Acetic Acid 2% Solution for Iontophoresis Vol. 6 No. 4 290
Ketorolac 6-mg/mL Solution for Iontophoresis Vol. 6 No. 4 291
Dehydroepiandrosterone 25-mg/mL in Pluronic Lecithin Organogel Vol. 6 No. 4 293
Dehydroepiandrosterone 25-mg/0.25-mL Sublingual Drops Vol. 6 No. 4 294
Estradiol 0.5-mg Sublingual Troches Vol. 6 No. 4 295
Estradiol 1-mg/0.1-mL Pluronic Lecithin Organogel Vol. 6 No. 4 296
Estradiol 1-mg/0.1-g Topical Cream Vol. 6 No. 4 297
Estriol 2-mg/mL, Estrone 0.25-mg/mL, and Estradiol 0.25-mg/mL Topical Solution Vol. 6 No. 4 298
Estriol 2-mg/mL Topical Gel Vol. 6 No. 4 299
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops Vol. 6 No. 4 300
Testosterone 25-mg in Oil Capsules Vol. 6 No. 4 301
Testosterone 50-mg/mL Topical Gel Vol. 6 No. 4 302
Topical Oil-in-Water Cream Bases, Featured Excipient: Vol. 6 No. 4 303
Calculations Vol. 6 No. 4 305
Standard Operaing Procedure for the Quality Assessment of Nasal Solutions Vol. 6 No. 4 306
Stability of Tubocurarine Chloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 4 308
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Vol. 6 No. 4 311
Stability of Ketamine Hydrochloride Injection After Reconstitution in Water for Injection and Storage in 1-mL Tuberculin Polypropylene Syringes for Pediatric Use Vol. 6 No. 4 316
PostScription: Certification: Now Is the Time Vol. 6 No. 4 320
Navigating New Territories in Compounding for Veterinary Medicine Vol. 6 No. 5 324
Total Parenteral Nutrition for Animals Vol. 6 No. 5 328
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs Vol. 6 No. 5 332
Rites of Passage Vol. 6 No. 5 337
Drug Therapy for Acute and Chronic Pain in the Cat Vol. 6 No. 5 338
Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism Vol. 6 No. 5 344
Excerpts from and Reviews of Current Published Literature: Veterinary Topics Vol. 6 No. 5 346
Veterinary Book Reviews Vol. 6 No. 5 349
Compounding in History: Equine Health Vol. 6 No. 5 350
Spavin Treatment Vol. 6 No. 5 351
Cough Ball (Veterinary) Vol. 6 No. 5 351
Horse Liniment Vol. 6 No. 5 351
Quality in Pharmacy: The New Zealand Experience Vol. 6 No. 5 354
Third-Party Contracting for Compounding Pharmacies Vol. 6 No. 5 359
Basics of Compounding: Phonophoresis Vol. 6 No. 5 362
Ultrasound Gels-Carbopol Type Vol. 6 No. 5 363
Ultrasound Gels-Hydoxyethyl Cellulose Type Vol. 6 No. 5 363
Betamethasone Dipropionate 0.05% Gel for Phonophoresis Vol. 6 No. 5 364
Piroxicam 0.5% Gel for Phonophoresis Vol. 6 No. 5 364
Dexamethasone Sodium 0.4% Gel for Phonophoresis Vol. 6 No. 5 364
Fluocinonide 0.1% Gel for Phonophoresis Vol. 6 No. 5 364
Ketoprofen 2% Gel for Phonophoresis Vol. 6 No. 5 364
Naproxen 5% Gel for Phonophoresis Vol. 6 No. 5 364
Sodium Salicylate 10% Gel for Phonophoresis Vol. 6 No. 5 364
Hydrocortisone 10% Gel for Phonophoresis Vol. 6 No. 5 364
Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel Vol. 6 No. 5 365
Zinc Oxide 20% Gel Vol. 6 No. 5 365
Iodine and Methylsalicylate Ultrasound Ointment Vol. 6 No. 5 365
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Vol. 6 No. 5 367
Ketoprofen 10% in Pluronic Lecithin Organogel Vol. 6 No. 5 368
Oral Liquid Vehicle for Equine Use Vol. 6 No. 5 369
Phenytoin Topical Powder Vol. 6 No. 5 370
Tetracycline and Hydrocortisone Otic Suspension Vol. 6 No. 5 371
Veterinary Carminative Vol. 6 No. 5 372
Oral Liquid for Diarrhea Vol. 6 No. 5 373
Veterinary Penicillamine 20-mg/mL Oral Liquid, Avian Vol. 6 No. 5 374
Veterinary Thrush Formula, Equine Vol. 6 No. 5 375
Veterinary Topical Anesthetic and Astringent Gel Vol. 6 No. 5 376
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy Vol. 6 No. 5 377
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix Vol. 6 No. 5 378
Featured Excipient: Specially Denatured Alcohols Vol. 6 No. 5 380
Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients Vol. 6 No. 5 384
Calculations Vol. 6 No. 5 387
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 5 388
Effect of Freezing, Long-Term Storage, and Microwave Thawing on the Stability of Cefepime in 5% Dextrose Infusion Polyvinyl Chloride Bags Vol. 6 No. 5 391
Chemical Stability of Dexamethasone Sodium Phosphate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes Vol. 6 No. 5 395
PostScription: Exec. VP & CEO NCPA Vol. 6 No. 5 400
The Cost of Quality in Pharmacy Vol. 6 No. 6 404
Comparison of Endotoxin Testing Methods for Pharmaceutical Products Vol. 6 No. 6 408
Phenytoin Injections: From Compounding to Cerebyx Vol. 6 No. 6 410
Book Review: Sterile Compounding Vol. 6 No. 6 414
Sterile Compounding of Respiratory Inhalation Solutions Vol. 6 No. 6 415
Pediatric Dermatitis Vol. 6 No. 6 419
Excerpts from and Reviews of Current Published Literature: Pediatric Medications Vol. 6 No. 6 423
Book Reviews: Compounding for Pediatric Patients Vol. 6 No. 6 424
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1 Vol. 6 No. 6 428
Regulatory and Operational Issues of Founding a Compounding Pharmacy Vol. 6 No. 6 434
Technology Spotlight: Liquid-Filling Machines Vol. 6 No. 6 439
Medications Discontinued in the United States Vol. 6 No. 6 441
Basics of Compounding: Clinical Studies Vol. 6 No. 6 443
Benzalkonium Chloride 1:750 Solution for Cold Disinfection Vol. 6 No. 6 448
Caffeine and Sodium Benzoate 250-mg/mL Injection Vol. 6 No. 6 449
Dexamethasone Sodium Phosphate 4-mg/mL Injection Vol. 6 No. 6 450
Dimenhydrinate 50-mg/mL Injection Vol. 6 No. 6 451
Erythromycin and Dexamethasone Ophthalmic Solution Vol. 6 No. 6 452
Furosemide 10-mg/mL Injection Vol. 6 No. 6 453
Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia Vol. 6 No. 6 454
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection Vol. 6 No. 6 455
Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia Vol. 6 No. 6 456
Phenobarbital Sodium 130-mg/mL Injection Vol. 6 No. 6 457
Andropause: A Review of Treatment Options Vol. 6 No. 6 458
Featured Excipient: Disinfecting Agents Vol. 6 No. 6 462
Calculations Vol. 6 No. 6 465
Cleaning and Disinfection Vol. 6 No. 6 466
Chemical Stability of Furosemide in Minibags and Polypropylene Syringes Vol. 6 No. 6 468
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes Vol. 6 No. 6 471
Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 6 No. 6 475
PostScription: The Times They Are A-Changin Vol. 6 No. 6 480